Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

World Wide Alzheimer's Disease Neuroimaging Initiative

Korea ADNI

Korean ADNI (K-ADNI) is working to comply with international standards of world-wide ADNI for development of new drugs for Alzheimer's Disease dementia patients;  to evaluate the effects of vascular risk factors on Alzheimer's disease progression and Subcortical Vascular Dementia (SVaD), which comprises relatively large proportion of Asian dementia patients; and to establish the efficacy approval system for new dementia drugs.  They are recruiting and collecting data comparable to that gathered through other WW-ADNI centers and data collected throughout this study are available to the research community. Recently, Korea ADNI was approved for government funding.

View more information about Korean ADNI.


Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.

Korea Korea